Total Payments
$3,211
2024 Payments
$60.87
Companies
31
Transactions
219
Medicare Patients
5,332
Medicare Billing
$137,693
Payment Breakdown by Category
Food & Beverage$3,211 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,211 | 219 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $455.30 | 32 | $0 (2019) |
| Amgen Inc. | $442.66 | 24 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $338.14 | 29 | $0 (2018) |
| Merck Sharp & Dohme Corporation | $253.89 | 17 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $176.34 | 6 | $0 (2018) |
| Eisai Inc. | $165.31 | 12 | $0 (2021) |
| Lilly USA, LLC | $153.37 | 15 | $0 (2018) |
| Novo Nordisk Inc | $152.89 | 18 | $0 (2018) |
| AbbVie, Inc. | $151.64 | 5 | $0 (2019) |
| Amarin Pharma Inc. | $104.07 | 5 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $60.87 | 4 | Amgen Inc. ($28.94) |
| 2022 | $37.32 | 3 | GlaxoSmithKline, LLC. ($37.32) |
| 2021 | $55.65 | 4 | Eisai Inc. ($55.65) |
| 2020 | $85.57 | 6 | Eisai Inc. ($85.57) |
| 2019 | $367.50 | 23 | AstraZeneca Pharmaceuticals LP ($161.85) |
| 2018 | $787.15 | 47 | AstraZeneca Pharmaceuticals LP ($159.16) |
| 2017 | $1,817 | 132 | Amgen Inc. ($385.07) |
All Payment Transactions
219 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/09/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $13.20 | General |
| Category: Psychology/Psychiatric | ||||||
| 09/25/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.73 | General |
| Category: RESPIRATORY | ||||||
| 07/08/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $14.47 | General |
| Category: Cardiology | ||||||
| 07/08/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $14.47 | General |
| Category: Cardiology | ||||||
| 11/28/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $12.73 | General |
| Category: RESPIRATORY | ||||||
| 09/02/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $12.49 | General |
| Category: RESPIRATORY | ||||||
| 05/13/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $12.10 | General |
| Category: RESPIRATORY | ||||||
| 11/09/2021 | Eisai Inc. | Dayvigo (Drug) | Food and Beverage | Cash or cash equivalent | $15.32 | General |
| Category: Neurology | ||||||
| 05/18/2021 | Eisai Inc. | Dayvigo (Drug) | Food and Beverage | Cash or cash equivalent | $12.79 | General |
| Category: Neurology | ||||||
| 03/23/2021 | Eisai Inc. | Dayvigo (Drug) | Food and Beverage | Cash or cash equivalent | $13.63 | General |
| Category: Neurology | ||||||
| 02/22/2021 | Eisai Inc. | Dayvigo (Drug) | Food and Beverage | Cash or cash equivalent | $13.91 | General |
| Category: Neurology | ||||||
| 12/10/2020 | Eisai Inc. | Dayvigo (Drug) | Food and Beverage | Cash or cash equivalent | $14.55 | General |
| Category: Neurology | ||||||
| 10/14/2020 | Eisai Inc. | Dayvigo (Drug) | Food and Beverage | Cash or cash equivalent | $13.74 | General |
| Category: Neurology | ||||||
| 09/14/2020 | Eisai Inc. | Dayvigo (Drug) | Food and Beverage | Cash or cash equivalent | $12.45 | General |
| Category: Neurology | ||||||
| 08/20/2020 | Eisai Inc. | Dayvigo (Drug) | Food and Beverage | Cash or cash equivalent | $16.43 | General |
| Category: Neurology | ||||||
| 06/17/2020 | Eisai Inc. | Dayvigo (Drug) | Food and Beverage | Cash or cash equivalent | $14.32 | General |
| Category: Neurology | ||||||
| 06/04/2020 | Eisai Inc. | Dayvigo (Drug) | Food and Beverage | Cash or cash equivalent | $14.08 | General |
| Category: Neurology | ||||||
| 06/24/2019 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $15.91 | General |
| 06/10/2019 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $23.52 | General |
| Category: Hypertriglyceridemia | ||||||
| 05/13/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $12.12 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/30/2019 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $15.57 | General |
| Category: Hypertriglyceridemia | ||||||
| 04/17/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $28.40 | General |
| Category: DIABETES | ||||||
| 04/15/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.16 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/03/2019 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $15.43 | General |
| Category: Respiratory | ||||||
| 03/18/2019 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $20.89 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 21 | 794 | 876 | $46,404 | $16,895 |
| 2022 | 24 | 1,572 | 1,947 | $97,964 | $37,584 |
| 2021 | 28 | 1,473 | 1,981 | $110,173 | $43,679 |
| 2020 | 28 | 1,493 | 1,908 | $110,050 | $39,535 |
Total Patients
5,332
Total Services
6,712
Medicare Billing
$137,693
Procedure Codes
101
All Medicare Procedures & Services
101 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 63 | 77 | $12,270 | $3,779 | 30.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 23 | 28 | $5,835 | $2,158 | 37.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 13 | 13 | $3,237 | $1,667 | 51.5% |
| 82306 | Vitamin d-3 level | Office | 2023 | 46 | 47 | $3,525 | $1,363 | 38.7% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 50 | 54 | $2,592 | $888.84 | 34.3% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 51 | 56 | $2,072 | $734.72 | 35.5% |
| 84403 | Testosterone (hormone) level, total | Office | 2023 | 25 | 27 | $1,917 | $682.83 | 35.6% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 45 | 46 | $1,932 | $679.88 | 35.2% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2023 | 32 | 37 | $1,887 | $666.74 | 35.3% |
| 84402 | Testosterone (hormone) level, free | Office | 2023 | 24 | 26 | $1,820 | $648.96 | 35.7% |
| 82746 | Folic acid level, serum | Office | 2023 | 44 | 45 | $1,845 | $648.45 | 35.1% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 50 | 56 | $1,624 | $579.60 | 35.7% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 47 | 53 | $1,431 | $504.56 | 35.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 53 | 59 | $590.00 | $495.60 | 84.0% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 51 | 57 | $1,254 | $433.77 | 34.6% |
| 82044 | Urine microalbumin (protein) analysis | Office | 2023 | 47 | 53 | $689.00 | $323.83 | 47.0% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2023 | 47 | 53 | $795.00 | $269.24 | 33.9% |
| 83735 | Magnesium level | Office | 2023 | 23 | 23 | $437.00 | $151.11 | 34.6% |
| 83540 | Iron level | Office | 2023 | 11 | 14 | $252.00 | $88.76 | 35.2% |
| 81003 | Automated urinalysis test | Office | 2023 | 32 | 34 | $238.00 | $74.80 | 31.4% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2023 | 17 | 18 | $162.00 | $55.98 | 34.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 90 | 127 | $19,050 | $7,192 | 37.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 51 | 51 | $12,277 | $6,746 | 54.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 40 | 51 | $11,169 | $3,783 | 33.9% |
| 82306 | Vitamin d-3 level | Office | 2022 | 91 | 112 | $8,400 | $3,249 | 38.7% |
About Dr. Edwin Matthews, M.D
Dr. Edwin Matthews, M.D is a Internal Medicine healthcare provider based in Irving, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1588607030.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Edwin Matthews, M.D has received a total of $3,211 in payments from pharmaceutical and medical device companies, with $60.87 received in 2024. These payments were reported across 219 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($3,211).
As a Medicare-enrolled provider, Matthews has provided services to 5,332 Medicare beneficiaries, totaling 6,712 services with total Medicare billing of $137,693. Data is available for 4 years (2020–2023), covering 101 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Irving, TX
- Active Since 06/13/2006
- Last Updated 11/26/2019
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1588607030
Products in Payments
- FARXIGA (Drug) $308.00
- Prolia (Biological) $168.48
- Repatha (Biological) $167.73
- SOLIQUA (Drug) $151.07
- Dayvigo (Drug) $141.22
- TRULICITY (Drug) $126.00
- ZOSTAVAX (Biological) $105.21
- Vascepa (Drug) $104.07
- Otezla (Drug) $95.80
- TOUJEO (Drug) $95.21
- PRALUENT (Drug) $91.86
- Enbrel (Biological) $89.20
- Levemir (Drug) $84.23
- Trintellix (Drug) $68.32
- ASMANEX (Drug) $67.13
- InterFuse (Device) $66.83
- Victoza (Drug) $60.79
- GILENYA (Drug) $60.74
- SYMBICORT (Drug) $60.40
- TRELEGY ELLIPTA (Drug) $56.05
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Irving
Dr. Samata Basani, M.d, M.D
Internal Medicine — Payments: $302,290
Internal Medicine $302,290
Dr. Shiraj Sen, M.d, M.D
Internal Medicine — Payments: $81,865
Internal Medicine $81,865
Branden Snyder, M.d, M.D
Internal Medicine — Payments: $29,735
Internal Medicine $29,735
Ahmed Iqbal, M.d, M.D
Internal Medicine — Payments: $24,674
Internal Medicine $24,674
Nauman Siddiqi, Md, MD
Internal Medicine — Payments: $19,851
Internal Medicine $19,851
Dr. Enid Romanelli, M.d, M.D
Internal Medicine — Payments: $14,115
Internal Medicine $14,115